Salvage Surgery Following Systemic Therapy in Initially Unresectable Non‐Small Cell Lung Cancer
Salvage pulmonary surgery following systemic therapy is safe, yielding a 5-year OS rate of 75% in carefully selected patients with advanced NSCLC. Prevalent adenocarcinoma histology in the good-prognosis cohort is associated with superior outcomes.
Authors
- Junichi Shimizu (ORCID: https://orcid.org/0000-0003-1204-1371)
- Eiichi Sasaki (ORCID: https://orcid.org/0000-0002-6385-8341)
- Yoshitsugu Horio (ORCID: https://orcid.org/0000-0003-4661-6399)
- Yuta Matsubayashi
- Takuya Matsui (ORCID: https://orcid.org/0000-0001-9948-3249)
- Katsuhiro Masago (ORCID: https://orcid.org/0000-0003-3569-2978)
- Katsutoshi Seto (ORCID: https://orcid.org/0000-0003-0502-1655)
- Hisanori Iwashimizu
- Osamu Noritake
- Keiyu Sato
- Noriaki Sakakura (ORCID: https://orcid.org/0000-0002-9598-9629)
- Soichiro Suzuki (ORCID: https://orcid.org/0009-0006-4118-0222)
- Yutaka Fujiwara
- Hiroaki Kuroda
Institutions
- Aichi Cancer Center (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/1759-7714.70209
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00